News Conference News EAS 2017 Perceived Financial Barriers to Healthcare Worsen Cardiovascular Outcomes Even in Countries With Universal Medical Coverage Yael L. Maxwell April 27, 2017
News Daily News Genetic Predisposition to CAD Gets a Boost From Socioeconomics L.A. McKeown April 20, 2017
News Daily News Yo-Yo a No-No: Fluctuating Body Weight May Increase Morbidity and Mortality Among CAD Patients L.A. McKeown April 06, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Conference News ACC 2017 High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI Michael O'Riordan March 21, 2017
News Conference News ACC 2017 People Living in Amazon Rainforest Provide Clues to Coronary Protection L.A. McKeown March 17, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Conference News ACC 2017 Down and Out: Depressed CAD Patients Twice as Likely to Die as Those Without Depression L.A. McKeown March 09, 2017
News Conference News ACC 2017 More Certainty With Ceramides? New Blood Test May Help ID CAD Patients Early in Disease Yael L. Maxwell March 09, 2017
News Daily News Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction Yael L. Maxwell March 03, 2017
News Daily News Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy Michael O'Riordan January 18, 2017
News Daily News HIV-Positive Patients Face Elevated Rate of Type 2 MI Caitlin E. Cox January 12, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Daily News High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds Todd Neale December 19, 2016
News Daily News Statins Seem to Reduce Alzheimer’s Disease Risk, But Race/Ethnicity and Statin Type Matter Todd Neale December 14, 2016
News Daily News Al parecer las estatinas reducen el riesgo de la Enfermedad de Alzheimer, pero se deben tener en cuenta el tipo de estatina y la raza/etnicidad. Todd Neale December 14, 2016